The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Induction chemotherapy followed by chemoradiotherapy and TME for high-risk locally advanced rectal cancer with and without synchronous resectable metastases.
Carla Hajj
No relevant relationships to disclose
Martin R. Weiser
No relevant relationships to disclose
Aoife McErlean
No relevant relationships to disclose
Marc Gollub
No relevant relationships to disclose
Andrea Cercek
Research Funding - Lorus; Synta
Pei-Rong Ding
No relevant relationships to disclose
Leonard Saltz
No relevant relationships to disclose
Karyn A. Goodman
No relevant relationships to disclose